Media Center
- No
-
Category
- Show all
- Press Release
- News Article
- PR Video
- CEO Story
- Title
- Author
- Time uploaded
- Views
- Likes
- 17
- News Article
- News Article Dr. Lawrence Cher at Olivia Newton-Johns Cancer Wellness & Research Center/Austin Hospital is invited to present the interim data of Tanibirumab phase IIa recurrent GBM trial...
- 관리자
- 14 Jan 2019
- Views1234
- 0
- 16
- News Article
- News Article PharmAbcine`s ``BI(Business Incubation) Research Grant`` proposal is granted by KIAT.
- Manager
- 14 Jan 2019
- Views1483
- 1
- 15
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present for ``Investor Relation`` at MIRAE ASSET DAEWOO SECURITIES Corporate Day on July 12th, 2017.
- Manager
- 14 Jan 2019
- Views1349
- 1
- 14
- News Article
- News Article Interview of Dr. Jin-San Yoo, CEO of PharmAbcine with Bio-Pod
- Manager
- 14 Jan 2019
- Views1343
- 1
- 13
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine is presenting at the forum for future pharm in Seoul on June 23, 2017.
- Manager
- 14 Jan 2019
- Views1327
- 1
- 12
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine is presenting PharmAbcine`s R&D progress and the interim data of the ongoing phase IIa recurrent GBM trial...
- Manager
- 14 Jan 2019
- Views1355
- 1
- 11
- News Article
- News Article Dr. Lawrence Cher, principle investigator of Tanibirumab phase IIa recurrent GBM trial in Australia expose the interim data of the ongoing trial...
- Manager
- 14 Jan 2019
- Views1374
- 1
- 10
- News Article
- News Article Dr. Jin-San Yoo, CEO of PharmAbcine is invited to present PharmAbcine`s R&D progress at BIO LOGISTICS WORLD KOREA in Seoul on May 23-24, 2017.
- Manager
- 14 Jan 2019
- Views1405
- 1